brk344 ibuprofen sodium 80% active 20% inactive
TRANSCRIPT
Dynamics AX 2012 R2 Industry Solutions - Process Manufacturing
Johan HoffmannSenior Program ManagerMicrosoft Corporation
BRK344
Disclaimer© 2012 Microsoft Corporation. All rights reserved. Microsoft, Windows, Windows Vista and other product names are or may be registered trademarks and/or trademarks in the U.S. and/or other countries. Other names and brands may be claimed as the property of others.
Microsoft Dynamics AX 2012 R2 is a pre-release product under development. The information herein is for informational purposes only and represents the current view of Microsoft Corporation as of the date of this presentation. Because Microsoft must respond to changing market conditions, it should not be interpreted to be a commitment on the part of Microsoft. Microsoft cannot guarantee the accuracy of any information provided after the date of this presentation. All product release dates and features specified are preliminary based on current expectations, and are subject to change without notice. Microsoft may make changes to specifications and product descriptions at any time, without notice.
Sample code included in this presentation is made available AS IS. THE ENTIRE RISK OF THE USE OR THE RESULTS FROM THE USE OF THIS CODE REMAINS WITH THE USER.
MICROSOFT MAKES NO WARRANTIES, EXPRESS, IMPLIED OR STATUTORY, AS TO THE INFORMATION IN THIS PRESENTATION. NO LICENSE, EXPRESS OR IMPLIED, BY ESTOPPEL OR OTHERWISE, TO ANY INTELLECTUAL PROPERTY RIGHTS IS GRANTED BY THIS PRESENTATION. Microsoft products are not intended for use in medical, life saving, or life sustaining applications.
Session Focus
Pricing products with potency
Batch balancing active
ingredientsLot inheritance Sequencing
Challenges
Change over and cleanups
Product specification and traceability
Pricing and consumption of products with potency
Potency Management
Ibuprofen Sodium
80% Active
20% Inactive
Attribute-based Pricing
80% Active =
$96.01 kg
1 kg
78.5% Active =
$94.2
1 kg84.7%
Active = $101.64
Purchase price = (Actual / Target) * Target price
Demo Potency management Attribute-based pricing
TO PRODUCE
1.000.000 Capsules (450 mg) = 450 kg
YOU NEED
250 kg, Ibuprofen Sodium 80%50 kg, Colloidial Silicon Dioxide35 kg, Corn Starch 28 kg, Croscarmellose Sodium15 kg, Hypromelloses9 kg, Steric Acid7 kg, Titanium Dioxide6 kg, Polysorbate 805 kg, Polyethylene Glycol
FORMULA
Potency – Formula Management
450 mg200 mg (active)
Ibuprofen Capsules
Potency – Formula Management
Ibuprofen Bulk
Formula size : 450 kg
Ibuprofen Capsule
200 mg (active)450 mg per capsule
Ingredient Ingredient type
Ibuprofen Sodium Active
Colloidal Silicon Dioxide
Compensating
Microcrystalline Cellulose
Filler
Corn Starch None
....
Potency Management
ActiveIngredient
CompensatingIngredient
Opposing effect
Complementary effect
Filler ingredient
(For achiving the required volume)
Demo Formulation Batch balancing
Lot Interitance
Human Skin TissueBlood Type: O +
Cell Culture 1Blood Type: O +
Cell Culture 2Blood Type: O +
Cell Culture 3Blood Type: O +
Cell Culture 4Blood Type: O +
Lot Interitance
Parent Item ABC: Steel Beam 100 ft.
Batch Attributes:•Tensile Strength•Compressive force•Shear strength•Duct ability•Coating
Child Item A: Steel Beam 50 ft.
Batch Attributes:•Tensile Strength•Compressive force•Shear strength•Duct ability•Coating
Child Item B: Steel Beam 50 ft.
Batch Attributes:•Tensile Strength•Compressive force•Shear strength•Duct ability•Coating
Lot Interitance
Length: 100 meters
Batch Attributes- Grade A Paper- Color: Flat White- Thickness: .18 Gauge--Weight: 80 gsm
Physical Dimensions
Item ABCJumbo Roll
Length: 100 meters
Width 41cm
Physical DimensionsItem BBBSlit Roll 1
Length: 100 meters
Width 41 cm
Physical Dimensions
Item CCCSlit Roll 2
Batch Attributes- Grade A Paper- Color: Flat White- Thickness: .18 Gauge--Weight: 80 gsm
Batch Attributes- Grade A Paper- Color: Flat White- Thickness: .18 Gauge--Weight: 80 gsm
Lot InteritanceExample: Kit
Expiry Date: 12/21/2012
Expiry Date: 12/19/2012
Expiry Date: 12/17/2012
Kit Components
Kit will inherit the earliest shelf life of 12/17/2012
Demo
Bulk Orange Juice
Juice Cartons
6 pack
• Shelf life• Ratio (Brix / Acidity)
Sequencing
Green
Blue
Minimizes ChangeoverAnd Cleanups
Yellow
Sequencing – Color - Size
2L
3L
5L
5L
3L
2L
2L
5L
3L
Bucket 1 Bucket 2 Bucket 3
Sequencing
2L 2L 5L 3L 5L 3L 5L 2L 3L 3L 5L 2L 3L 5L
3L 2L 5L 3L 5L 5L 2L
3L 3L 3L 2L 5L 5L 2L
2L 3L 5L 5L 3L
3L 5L 3L 5L 3L
After MRP
After sequencing
Sequencing period
Demo Sequencing
Top Tips From This Sessions
Potency item must have base attribute with a target valueA compensating ingredient line must have a compensating principle setup against an active ingredient lineA formula with an active ingredient line must go through batch balancing in production
Sequencing does not take material availability into accountRun MRP to get materials in sync or use negative days
Want More Information? Visit Us!
• Solution Architecture
• Manufacturing• Public Sector• Retail• Services Industries
Focus Rooms
• Dynamics Performance Mini Lab
• Microsoft SQL • Microsoft SQL BI• Bing Maps• Windows Phone• Visual Studio• Office
Microsoft Product Showcase
Innovate your Solutions Get Inspired
Share and Give Feedback
“The Microsoft R&D team is looking for customers and partners within the Chemical vertical who are interested to share and give feedback about the following areas within the supply chain: - Production planning and scheduling - Plant management. such as profitability, asset and resource utilization , energy- Manufacturing execution and operation such as automated data collection from production equipment
information and sensors, track and trace of batches and ingredients within production - Logistics, such as transportation and shipping , inventory control
Our interest is to understand your business , so we can build even better applications in the future. ….if you are interested please leave your business card or just grab me after the session”
© 2012 Microsoft Corporation. All rights reserved. Microsoft, Windows, and other product names are or may be registered trademarks and/or trademarks in the U.S. and/or other countries.The information herein is for informational purposes only and represents the current view of Microsoft Corporation as of the date of this presentation. Because Microsoft must respond to changing market conditions, it should not be interpreted to be a commitment on the part of Microsoft, and Microsoft cannot guarantee the accuracy of any information provided after the date of this presentation. MICROSOFT MAKES NO WARRANTIES, EXPRESS, IMPLIED OR STATUTORY, AS TO THE INFORMATION IN THIS PRESENTATION.